We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Classic Laparoscopy Technique Preferred for Gallbladder Surgery

By HospiMedica International staff writers
Posted on 02 Jun 2011
Procedure times are longer and complications more frequent with single-port laparoscopic cholecystectomy than with the traditional four-port technique, according to a new study.

Researchers at Providence Portland Medical Center (OR, USA) conducted a study to compare short-term surgical outcomes and quality of life (QOL) in 43 eligible patients randomized to single-port laparoscopic cholecystectomy (SPLC, 21 patients) and classic 4-port laparoscopic cholecystectomy (CLC, 22 patients). More...
There were no significant differences between groups for most preoperative demographics, American Society of Anesthesiology (ASA) score, gallstone characteristics, local inflammation, blood loss, or length of stay.

The results showed that patients undergoing SPLC were older than those receiving CLC (57.3 years versus 45.8 years). Operative times for SPLC were greater than CLC; overall and cosmetic satisfaction, QOL as determined by the SF-36 survey, postoperative complications, and post-operative pain scores between discharge and two-week postoperative visit were not significantly different between groups. Wound infection rates were also similar in both groups. The SPLC group contained one retained bile duct stone, one port site hernia, and one postoperative port site hemorrhage. The study was published on April 13, 2011, in Annals of Surgery.

"In summary, on the basis of our randomized controlled trial, single-port laparoscopic cholecystectomy had a longer operative time and seemed to incur more postoperative complications, which may be related to the learning curve," concluded lead author Paul Hansen, MD, and colleagues of the hepatobiliary and pancreatic surgery program. "However, both single-port laparoscopic cholecystectomy and classic laparoscopic cholecystectomy produced similar levels of patient satisfaction and pain, as well as patient-perceived functional health status."

Related Links:

Providence Portland Medical Center




Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Pressure Guidewire
SavvyWire
LED Surgical Lamp
ACEMST35/57
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.